Tumour necrosis factor inhibitors in Crohn's disease and the effect on surgery rates.
Michael EberhardsonPär MyrelidJonas K SöderlingAnders Ekbomnull nullÅsa H EverhovCharlotte R H HedinMartin NeoviusJonas F LudvigssonOla OlénPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2022)
Treatment with TNFi for less than 12 months was associated with a higher risk of bowel surgery in Crohn's disease patients compared with those who continued TNFi for 12 months or more.